Is Co Diagnostics Stock a Good Investment?
Co Diagnostics Investment Advice | CODX |
- Examine Co Diagnostics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Co Diagnostics' leadership team and their track record. Good management can help Co Diagnostics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Co Diagnostics' business and its evolving consumer preferences.
- Compare Co Diagnostics' performance and market position to its competitors. Analyze how Co Diagnostics is positioned in terms of product offerings, innovation, and market share.
- Check if Co Diagnostics pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Co Diagnostics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Co Diagnostics stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Co Diagnostics is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Co Diagnostics Stock
Researching Co Diagnostics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 17.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.2. Some equities with similar Price to Book (P/B) outperform the market in the long run. Co Diagnostics recorded a loss per share of 1.17. The entity had not issued any dividends in recent years.
To determine if Co Diagnostics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Co Diagnostics' research are outlined below:
| Co Diagnostics had very high historical volatility over the last 90 days | |
| Co Diagnostics has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 3.92 M. Net Loss for the year was (37.64 M) with profit before overhead, payroll, taxes, and interest of 2.71 M. | |
| Co Diagnostics currently holds about 86.49 M in cash with (29.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.8, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Co Diagnostics uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Co Diagnostics. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Co Diagnostics' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Co Diagnostics' market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.37 M.Basic technical analysis of CODX Stock
As of the 3rd of July, Co Diagnostics owns the Market Risk Adjusted Performance of (0.04), variance of 26.3, and Information Ratio of (0.03). Co Diagnostics technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices.Co Diagnostics' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Co Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Co Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Co Diagnostics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Co Diagnostics' Outstanding Corporate Bonds
Co Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Co Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CODX bonds can be classified according to their maturity, which is the date when Co Diagnostics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| CNO 175 07 OCT 26 Corp BondUS18977W2A75 | View | |
| CNO 265 06 JAN 29 Corp BondUS18977W2C32 | View | |
| US189754AC88 Corp BondUS189754AC88 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| NOVHOL 6625 15 APR 29 Corp BondUS18972EAA38 | View | |
| NOVHOL 875 15 APR 30 Corp BondUS18972EAB11 | View |
Understand Co Diagnostics' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Co Diagnostics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 4.06 | |||
| Coefficient Of Variation | (16,634) | |||
| Standard Deviation | 5.13 | |||
| Variance | 26.3 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 26.34 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 8.7 | |||
| Skewness | 0.4748 | |||
| Kurtosis | 0.4088 |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 4.06 | |||
| Coefficient Of Variation | (16,634) | |||
| Standard Deviation | 5.13 | |||
| Variance | 26.3 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.37) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 26.34 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 8.7 | |||
| Skewness | 0.4748 | |||
| Kurtosis | 0.4088 |
Consider Co Diagnostics' intraday indicators
Co Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Co Diagnostics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Co Diagnostics time-series forecasting models is one of many Co Diagnostics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Co Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
CODX Stock media impact
There is far too much social signal, news, headlines, and media speculation about Co Diagnostics that are available to investors today. This information is accessible both publicly - through Co Diagnostics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of CODX-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Co Diagnostics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Co Diagnostics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Co Diagnostics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Co Diagnostics alpha.
Co Diagnostics Corporate Management
| Christopher Thurston | Chief Officer | Profile | |
| Andrew Benson | Head Relations | Profile | |
| Mayuranki Almaula | Senior Alliances | Profile | |
| Dan CPA | Vice Accounting | Profile | |
| Ivory Chang | Chief Officer | Profile |
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.